Structural Heart Devices Market Size, Industry Analysis Report, Regional Outlook, Application Development Potential, Price Trends, Competitive Market Share & Forecast, 2021 – 2027

Structural Heart Devices Market size is forecasted to experience considerable growth from 2019 to 2025.
 

Structural heart devices market will witness a considerable growth in the near future due to increasing number of cardiac diseases. As per an article published by WHO, approximately 17.9 million people died from cardiovascular diseases in 2016, accounting 31% of entire global deaths. Hence, growing rate of cardiovascular diseases will augment the growth of structural heart devices market.
 

Rise in geriatric population will be one of the major factors responsible for the growth of structural heart devices market in the future. Since elderly population is prone to majority of the chronic diseases, such as cardiovascular diseases, cancer and diabetes, the mortality and morbidity rate is high among them. Also, with increasing technological advancements in the surgical procedures of cardiovascular diseases will augment the growth of the structural heart devices market.
 

One of the primary restraining factors of the structural heart devices market is high out of pocket expenditure. In the low-middle income countries, high cost associated cardiovascular disease management facilities are major barriers in the growth of the market. Additionally, lack of trained healthcare professionals to perform such complex heart procedures is another factor lagging the growth of the market.
 

Replacement devices market is estimated to witness considerable amount of growth in the forecast timeframe. Increasing use of these devices in case of valve replacement procedures, where patients mostly prefer invasive surgeries will boost product demand. Hence, rising demand for invasive surgical procedures will play significant role in the growth of structural heart devices market in future.
 

Geriatric population is the key segment augmenting the growth of the market. U.S. has a large number of geriatric population and as per American Heart Association, approximately 80% of the population who die of cardiovascular diseases are 65 or older. Thus, the rising population of geriatric age group will augment the growth of the market in the forecast time frame.

Structural heart devices market is expected to observe a considerable rate of growth in coming years, as the prevalence of mitral valvular disease is increasing at greater pace. The factors responsible for the rise in mitral valve diseases is due to the increasing rate of high blood pressure and geriatric population as well. These factors are increasing the prevalence of mitral valve diseases. Thus, supporting the growth of the market.
 

Hospitals as an end use is estimated to have considerable amount of market share. The growth is attributed to availability of technological advanced healthcare facilities. Increase in demand for technologically advance invasive procedures for efficient treatment of several cardiac ailments will augment the growth of structural heart devices market.
 

U.S. structural heart devices market is estimated to hold majority market share owing to continuous development of innovative technology. U.S. has focused on improving the reimbursement policies covering different types of cardiac treatments, thus augmenting the market demand. Additionally, awareness rate among the population of U.S. regarding medical treatment solutions are extremely high. Hence, recent technological advancements, favorable reimbursement policies and growing prevalence of chronic diseases will significantly drive the structural heart devices market in the country.

Structural heart devices market will observe a substantial growth in China during the forecast period. Rise in healthcare expenditure, growing awareness regarding the applications of structural heart devices and high rate of patients affected with coronary heart diseases will augment the business growth.
 

Major industry players such as, Edwards Lifesciences Corporation, Medtronic, Abbott, Boston Scientific Corporation, Livanova, Lepu Medical Technology, Cryolife, Micro Interventional Devices, Braile Biomédica and TTK Healthcare (A TTK Group Company) focuses mostly on strategic alliances, approvals and product launches as their primary market expansion strategies.

Structural Heart Devices Market, By Product

• Repair Devices
  • Occluders
  • Annuloplasty Rings
  • Heart Valve Balloons
  • Transcatheter Mitral Valve Repair
  • Others
• Replacement Devices
  • Transcatheter heart valve replacement
    • Transcatheter aortic valve
    • Transcatheter mitral valve
    • Transcatheter pulmonary valve
  • Surgical heart valve replacement
    • Tissue/Bioprosthetic heart valve
      • Stented tissue heart valve
      • Stentless tissue heart valve
      • Sutureless tissue heart valve
    • Mechanical heart valve

Structural Heart Devices Market, By Patient

• Pediatric
• Adult
• Geriatric

Structural Heart Devices Market, By Disease Indication

• Atrial Septal Defects (ASD)
• Ventricular Septal Defects (VSD)
• Aortic Valvular Diseases
• Mitral Valvular Disease
• Pulmonary Valvular Disease
• Patent Ductus Arteriosus (PDA)
• Patent Foramen Ovale
• Others

Structural Heart Devices Market, By End-use

• Hospitals
• Ambulatory Surgical Centers
• Cardiac Centers
• Others

The above information is provided for the following regions and countries:

• North America
  • U.S.
  • Canada
• Europe
  • Germany
  • UK
  • France
  • Italy
  • Spain
• Asia Pacific
  • Japan
  • China
  • India
  • Australia
• Latin America
  • Mexico
  • Brazil
  • Argentina
• Middle East and Africa
  • Saudi Arabia
  • South Africa
  • UAE

Company Profiles:

• Edwards Lifesciences Corporation
• Medtronic
• Livanova
• Boston Scientific Corporation
• Abbott
• Lepu Medical Technology
• Micro Interventional Devices
• Braile Biomédica
• Cryolife
• TTK Healthcare (A TTK Group Company)

What Information does this report contain?